Spatial Genomics & Transcriptomics Market size was valued at US$ 230.48 Mn in 2022 and the total revenue is expected to grow at 10.1 % through 2023 to 2029, reaching nearly US$ 452.01 Mn in the forecast period.Spatial Genomics & Transcriptomics Market Overview.
Genomics offers an overview of the complete genetic instruction given by DNA and transcription investigates gene expression patterns.To know about the Research Methodology :- Request Free Sample Report
Spatial Genomics & Transcriptomics Market Dynamics:
Spatial Genomics & Transcriptomics Market is growing with a CAGR of 10.1% during the forecast period at a rapid pace due to technological innovation and huge biomedical research activities carried out on gene mutation and advancement in gene therapy. Owing innovation in technologies has resulted in the shifting of conventional imaging technologies to high throughput sequencing technologies by identifying the positional information of RNA and DNA. The biopharmaceutical companies are focusing more on mergers and collaboration to sustain in the marge and gain huge revenues to generate profit in the market. Companies like Dovetail Genomics are focusing on the expansion of their business in coming years like Dovetail Genomics introduces a Dovetail™ Micro-C and HiChIP Kits. As result, this expansion will benefit the researcher's superior resolution of chromatin contacts down to the mono-nucleosome level. Dovetail HichIp is a powerful novel technology that combines with micro-C and Micro-C and chIp-sequencing to offers simple process management to facilitate the researchers Assay protein direct modification to chromatin. In addition, the spatial genomics and transcriptomics market has a huge demand in the field of disease. Moreover, spatially resolved Omics need more innovation for the development of the new method in the healthcare sector to motivate the market for future growth in the forecast period. In June 2021, The market player like Nanostring’s Digital Spatial is boosting the research activities on SAR-CoV-2 as the company is operating into FFPE samples specimens invented for COVID-19 Autopsies.Spatial Genomics & Transcriptomics Market Segment Analysis:
The Spatial transcriptomics technology is anticipated to adhere to the growth of the product segment of the Spatial Genomics & Transcriptomics Market. The segment special transcriptomics technology is gaining more attention in the market and has marked a revenue share of 83.4% in 2022. The growth of the segment is attributed to the high adoption of the transcriptomics segment as compared to the genomics segment for the analysis of single-cell transcriptomics. The growth of the special genomics and transcriptomics market is further accelerated due to the availability of automated sequencing methods like laser capture microdissection technique (LCM) to satisfy the requirement for nucleic acid sequencing of biological specimens. Moreover, the awareness about tissue heterogenicity has fueled the launches of unique sequencing technologies that are targeted for the storing of genomic or spatial information for future reference. And this factor is likely to initiate market growth in the forecast period. Besides the genomic perturbation tools like CRISPR/Cas9 system are likely to boost the application of genomic tools for the investigation of the mammalian genome that reveals the alteration leading towards a shift in phenotype. The consumables segment is supplementing the growth of the Spatial Genomics & Transcriptomics Market. Consumable’s segment is significantly boosting the market of spatial genomics and transcriptomics in the forecast period with a market share of 57.2% in 2022. The growth of the market is attributed to the factors like high product penetration, growing adoption of consumables, frequent use of kits and reagents for instruments in genomics and transcriptomics, and the vast availability of consumables. These instruments are used in genomic mapping for the preparation of sample specimens. Moreover, the advancements and additional feature in the consumables segment is boosting the adoption by the research in the biopharmaceuticals and research activities. The academic customers' segment is Trending in the End-User Segment of Spatial Genomics & Transcriptomics Market. The academic customer segment is dominating the end-user segment with 61.2% in 2022. The factor attributing to the growth of the market is the increasing application of genomics and transcriptomics by researchers in academic institutes. These techniques are widely used for the all-inclusive assessment of a wide range of diseases. For example, a research institute like Children’s Hospital for Philadelphia has experience in both locus discovery and GWAS in both academic and biotech settings. These organizations have installed a center for longitudinal and functional genomics to study the genetics of various diseases and the morphology of various diseases derives from genetic disorders like Cancer, Diabetes, and Alzheimer’s. Further, the Genomic and transcriptomics technology has wider opportunities in the sector like Human Cell Atlas. The segment has gained huge attention in the market with the largest market share in 2022 in the application of spatial Omics technologies in translational research activities. This factor is further boosting the application in various healthcare fields together with the launches of new diagnostic tools therapeutics. The growth is further stimulated by the other sub-segments like translational research, diagnostic centers, pharmaceuticals.Regional Insights:
Spatial Genomics & Transcriptomics Market is regionally segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is leading in the market due to the presence of renowned market players in North America like Illimina Inc and 10X Genomics. North America accounts for 47.2% of revenue share in the year 2022. Moreover, the strategic investment by the government and the market players in transcriptomics R & D and diseases pathology for the innovation of advanced diagnostic treatment and the tools is likely to Amplify the market growth of North America. Further, Illumina, Inc. invested USD 677 million in R&D for new sequence analysis technology to obtain rapid results. And this factor is stimulating the growth of the market. The Asia Pacific is estimated to grow at a significant pace due to growing mergers between diagnostic research centers and the Asia research institutes. The market players in the regions are further focusing on research activities carried out by emerging market players in the region. Further, the biotechnology market of China is proliferating with a CAGR of 8.1% in the forecast period and this is a factor that is inspiring the growth of the Spatial Genomics & Transcriptomics market in the Asia Pacific. The objective of the report is to present a comprehensive analysis of the Global Spatial Genomics & Transcriptomics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Spatial Genomics & Transcriptomics Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.Spatial Genomics & Transcriptomics Market Scope: Inquire before buying
Spatial Genomics & Transcriptomics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 230.48 Mn. Forecast Period 2023 to 2029 CAGR: 10.1% Market Size in 2029: US $ 452.01 Mn. Segments Covered: by Product Instruments By Mode Automated Semi-automated By Type Sequencing Platforms IHC by Technology Spatial Transcriptomics IHC Spatial Genomics FISH Microscopy-based Live DNA Imaging by End-Use Translational Research Academic Customers Diagnostic Customers Pharmaceutical Manufacturer Spatial Genomics & Transcriptomics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Key Players:
1. Natera Inc. 2. 10x Genomics 3. Dovetail Genomics 4. Illumina, Inc. 5. S2 Genomics, Inc. 6. NanoString Technologies, Inc. 7. Seven Bridges Genomics 8. Horizon Discovery Group plc 9. CARTANA AB 10. READCOOR, INC. 11. Bio-TechneFAQs:
1. What is the global Spatial Genomics & Transcriptomics market share in 2022? Ans: Approximately, 230.48 million USD. 2. What is the global Spatial Genomics & Transcriptomics market growth? Ans: The global Spatial Genomics & Transcriptomics market is anticipated to grow with a CAGR of 10.1% in the forecast period and is likely to reach 452.01 million by the end of 2029. 3. Which technology is expected to dominate the global Spatial Genomics & Transcriptomics market during the forecast period? Ans: The segment special transcriptomics technology is dominating in the market and with 83.4% in 2022. The growth of the segment is attributed to the high adoption of the transcriptomics segment as compared to the genomics segment for the analysis of single-cell transcriptomics. 4. Which region is expected to dominate the global Spatial Genomics & Transcriptomics market during the forecast period? Ans: North America dominates the Spatial Genomics & Transcriptomics market owing to increasing strategic investment by the market players like Illimina Inc and 10X Genomics. 5. What are the key driving factors for the growth of the global Spatial Genomics & Transcriptomics market? Ans: The factors driving the market are technological innovation and huge biomedical research activities carried out on gene mutation and advancement in gene therapy.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Technology 2.3.2. Primary Research 2.3.2.1. Data from Primary Technology 2.3.2.2. Breakdown of Primary Technology 3. Executive Summary: Global Spatial Genomics & Transcriptomics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Spatial Genomics & Transcriptomics Market 3.4. Geographical Snapshot of the Spatial Genomics & Transcriptomics Market, By Manufacturer share 4. Global Spatial Genomics & Transcriptomics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Spatial Genomics & Transcriptomics Market 5. Supply Side and Demand Side Indicators 6. Global Spatial Genomics & Transcriptomics Market Analysis and Forecast, 2022-2029 6.1. Global Spatial Genomics & Transcriptomics Market Size & Y-o-Y Growth Analysis. 7. Global Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 7.1.1. Instruments 7.1.1.1. By Mode 7.1.1.1.1. Automated 7.1.1.1.2. Semi-automated 7.1.1.1.3. Manual 7.1.1.2. By Type 7.1.1.2.1. Sequencing Platforms 7.1.1.2.2. IHC 7.1.1.2.3. Microscopy 7.1.1.2.4. Flow Cytometry 7.1.1.2.5. Mass Spectrometry 7.1.1.2.6. Others 7.1.2. Consumables 7.1.3. Software 7.1.3.1. Bioinformatics Tools 7.1.3.2. Imaging Tools 7.1.3.3. Storage and Management Databases 7.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 7.2.1. Spatial Transcriptomics 7.2.2. IHC 7.2.3. Microscopy-based RNA Imaging Techniques 7.2.4. Spatial Genomics 7.2.4.1. FISH 7.2.4.2. Microscopy-based Live DNA Imaging 7.2.4.3. Genome Perturbation Tools 7.2.4.4. Massively parallel Sequencing 7.2.4.5. Biochemical Techniques 7.2.4.6. Others 7.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 7.3.1. Translational Research 7.3.2. Academic Customers 7.3.3. Diagnostic Customers 7.3.4. Pharmaceutical Manufacturer 8. Global Spatial Genomics & Transcriptomics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 9.1.1. Instruments 9.1.1.1. By Mode 9.1.1.1.1. Automated 9.1.1.1.2. Semi-automated 9.1.1.1.3. Manual 9.1.1.2. By Type 9.1.1.2.1. Sequencing Platforms 9.1.1.2.2. IHC 9.1.1.2.3. Microscopy 9.1.1.2.4. Flow Cytometry 9.1.1.2.5. Mass Spectrometry 9.1.1.2.6. Others 9.1.2. Consumables 9.1.3. Software 9.1.3.1. Bioinformatics Tools 9.1.3.2. Imaging Tools 9.1.3.3. Storage and Management Databases 9.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 9.2.1. Spatial Transcriptomics 9.2.2. IHC 9.2.3. Microscopy-based RNA Imaging Techniques 9.2.4. Spatial Genomics 9.2.4.1. FISH 9.2.4.2. Microscopy-based Live DNA Imaging 9.2.4.3. Genome Perturbation Tools 9.2.4.4. Massively parallel Sequencing 9.2.4.5. Biochemical Techniques 9.2.4.6. Others 9.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 9.3.1. Translational Research 9.3.2. Academic Customers 9.3.3. Diagnostic Customers 9.3.4. Pharmaceutical Manufacturer 10. North America Spatial Genomics & Transcriptomics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 12. Canada Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 13. Mexico Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 14. Europe Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 15. Europe Spatial Genomics & Transcriptomics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 17. France Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 18. Germany Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 19. Italy Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 20. Spain Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 21. Sweden Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 22. CIS Countries Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 23. Rest of Europe Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 24. Asia Pacific Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 25. Asia Pacific Spatial Genomics & Transcriptomics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 27. India Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 28. Japan Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 29. South Korea Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 30. Australia Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 31. ASEAN Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 32. Rest of Asia Pacific Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 33. Middle East Africa Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 34. Middle East Africa Spatial Genomics & Transcriptomics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 36. GCC Countries Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 37. Egypt Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 38. Nigeria Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 39. Rest of ME&A Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 40. South America Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 41. South America Spatial Genomics & Transcriptomics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 43. Argentina Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 44. Rest of South America Spatial Genomics & Transcriptomics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product’s, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End-Use, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Spatial Genomics & Transcriptomics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Illumine Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Natera Inc. 45.3.3. 10x Genomics 45.3.4. Dovetail Genomics 45.3.5. Illumina, Inc. 45.3.6. S2 Genomics, Inc. 45.3.7. NanoString Technologies, Inc. 45.3.8. Seven Bridges Genomics 45.3.9. Horizon Discovery Group plc 45.3.10. CARTANA AB 45.3.11. READCOOR, INC. 45.3.12. Bio-Techne Primary Key Insights